صفحه 1 از جانب 158 نتایج
PRIORITY STATEMENT
This application claims benefit of priority as applicable under 35 U.S.C. .sctn.120 as a continuation of PCT/US2008/056035, filed Mar. 6, 2008, which claims benefit under 35 U.S.C. .sctn.119(e) of U.S. Provisional Application No. 60/905,237, filed Mar. 6, 2007.
FIELD OF THE
FIELD OF THE INVENTION
The present invention provides for novel liquid and solid, sustained release formulations of antioxidants for intraocular and intratumoral injection or implantation as novel methods of treatment of ocular afflictions and tumors/cancer.
BACKGROUND
In Earth's oxygen rich
TECHNICAL FIELD
This application relates to the area of anticancer therapeutics, more specifically, the application relates to the area of cancer immunotherapy. Specifically, the application discloses means of decreasing toxicity associated with immunotherapeutic interventions, while concurrently
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to new hydrophobic ascorbic ester compounds, which are synthesized by linking ascorbic acid either wit monomer prostaglandin B.sub.2 or with oligomeric derivatives of prostaglandin B.sub.2, as well as to methods of
BACKGROUND OF THE INVENTION
A pharmaceutical composition for prevention and treatment of cancer, cardiovascular disease and antioxidation contains resveratol. The new method of process for producing resveratol is extracted resveratol from oil residue and stems of peanuts or stems of other cheap
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention provides prophylactic, therapeutic and industrial antioxidant compositions that are enhanced with stabilized atomic hydrogen/free electrons. The invention also provides methods to prepare and use such antioxidant compositions.
2.
CROSS REFERENCE TO RELATED APPLICATION
This application is a national stage of international application No. PCT/JP2009/050020 filed on Jan. 6, 2009, which also claims priority under 35 USC 119 to Japanese Patent Application No. 2008-001801 filed Jan. 9, 2008, the entire content of which are
This application is a 371 of PCT/JP95/01975 filed Sep. 28, 1995.
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a novel tricyclic, condensed heterocyclic compound. The novel tricyclic, condensed heterocyclic compound in accordance with the present invention is a useful substance
FIELD OF THE INVENTION
The present invention relates to the use of antioxidants to treat tumour cells; to pharmaceutical compositions containing antioxidants adapted for such use; and, to methods for the treatment of tumour cells by administering antioxidants.
BACKGROUND OF THE INVENTION
Ionizing
FIELD OF THE INVENTION
The present invention relates to the use of antioxidants to treat tumour cells; to pharmaceutical compositions containing antioxidants adapted for such use; and, to methods for the treatment of tumour cell by administering antioxidants.
BACKGROUND OF THE INVENTION
Ionizing
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
REFERENCE TO A "MICROFICHE APPENDIX"
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to hydroquinone substituted polyunsaturated fatty acids. More particularly, the
FIELD OF THE INVENTION
The present invention relates to compositions comprising a combination of at least one source of .delta.-tocols (tocotrienol and/or tocopherol), with an antioxidant source comprising polyphenolic compounds. Due to synergistic effects, such compositions are useful in treating
BACKGROUND FIELD OF THE INVENTION
A Natural organic sunscreen composition for external application which contains natural organic medicinal properties, (The term "organic" as used herein refers to the fact that no heat or chemical substances have been added to the natural sunscreen
The present invention relates to new tert-butyl derivatives of benzylidenecamphor, to a process for preparing them and to their uses as antioxidant agents as well as in cosmetic compositions for daily use or for protection against sunlight and in pharmaceutical compositions for the preventive
The present invention relates to new tert-butyl derivatives of benzylidenecamphor, to a process for preparing them and to their uses as antioxidant agents as well as in cosmetic compositions for daily use or for protection against sunlight and in pharmaceutical compositions for the preventive